Jessica Fye
Stock Analyst at J.P. Morgan
(4.53)
# 1,013
Out of 4,371 analysts
568
Total ratings
55.7%
Success rate
9.3%
Average return
Main Sectors:
Stocks Rated by Jessica Fye
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| JAZZ Jazz Pharmaceuticals | Maintained: Buy | n/a | $240.06 | - | 32 | Jun 2, 2026 | |
| ONC BeOne Medicines AG | Maintained: Buy | n/a | $279.93 | - | 12 | Jun 2, 2026 | |
| AKTS Aktis Oncology | Initiated Coverage: Buy | $30 | $19.89 | +50.83% | 1 | Feb 3, 2026 | |
| ASND Ascendis Pharma | Reiterated: Buy | n/a | $218.84 | - | 46 | Nov 13, 2025 | |
| IONS Ionis Pharmaceuticals | Maintained: Buy | n/a | $75.13 | - | 28 | Nov 9, 2025 | |
| NKTR Nektar Therapeutics | Maintained: Sell | $30 | $59.31 | -49.42% | 31 | Nov 9, 2025 | |
| DNLI Denali Therapeutics | Maintained: Buy | $26 | $20.14 | +29.10% | 16 | Nov 3, 2025 | |
| STOK Stoke Therapeutics | Maintained: Hold | $15 → $25 | $30.12 | -17.00% | 17 | Nov 3, 2025 | |
| BMRN BioMarin Pharmaceutical | Maintained: Buy | n/a | $56.47 | - | 16 | Oct 27, 2025 | |
| HALO Halozyme Therapeutics | Maintained: Hold | $63 → $65 | $71.60 | -9.22% | 19 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $25 → $23 | $17.99 | +27.85% | 14 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $26 → $25 | $51.59 | -51.54% | 20 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $121 → $120 | $89.59 | +33.94% | 29 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $101.24 | - | 23 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $10 | $13.80 | -27.54% | 10 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $45.33 | - | 3 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $473 | $303.64 | +55.78% | 22 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $78 → $76 | $34.20 | +122.22% | 12 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $517 → $530 | $441.74 | +19.98% | 21 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $53 → $52 | $34.63 | +50.16% | 15 | Sep 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $53 → $77 | $92.49 | -16.75% | 11 | Sep 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $34 → $35 | $43.38 | -19.32% | 13 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $153 | $104.92 | +45.83% | 24 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $450 | $547.69 | -17.84% | 32 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $30.91 | - | 3 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $13 | $8.47 | n/a | 18 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 | $28.76 | n/a | 14 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Sell | n/a | $8.44 | n/a | 13 | Nov 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $3.13 | n/a | 18 | Nov 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $18 → $14 | $25.10 | n/a | 4 | Jun 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 → $5 | $1.90 | n/a | 12 | Apr 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $19 | $3.05 | n/a | 4 | Mar 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $0.7753 | n/a | 3 | Aug 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $13 → $7 | $84.12 | n/a | 3 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $94 → $66 | $148.08 | n/a | 2 | Apr 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $10.19 | n/a | 3 | Mar 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $32 → $95 | $11.79 | n/a | 4 | Feb 8, 2018 |
Jazz Pharmaceuticals
Jun 2, 2026
Maintained: Buy
Price Target: n/a
Current: $240.06
Upside: -
BeOne Medicines AG
Jun 2, 2026
Maintained: Buy
Price Target: n/a
Current: $279.93
Upside: -
Aktis Oncology
Feb 3, 2026
Initiated Coverage: Buy
Price Target: $30
Current: $19.89
Upside: +50.83%
Ascendis Pharma
Nov 13, 2025
Reiterated: Buy
Price Target: n/a
Current: $218.84
Upside: -
Ionis Pharmaceuticals
Nov 9, 2025
Maintained: Buy
Price Target: n/a
Current: $75.13
Upside: -
Nektar Therapeutics
Nov 9, 2025
Maintained: Sell
Price Target: $30
Current: $59.31
Upside: -49.42%
Denali Therapeutics
Nov 3, 2025
Maintained: Buy
Price Target: $26
Current: $20.14
Upside: +29.10%
Stoke Therapeutics
Nov 3, 2025
Maintained: Hold
Price Target: $15 → $25
Current: $30.12
Upside: -17.00%
BioMarin Pharmaceutical
Oct 27, 2025
Maintained: Buy
Price Target: n/a
Current: $56.47
Upside: -
Halozyme Therapeutics
Oct 27, 2025
Maintained: Hold
Price Target: $63 → $65
Current: $71.60
Upside: -9.22%
Oct 27, 2025
Maintained: Hold
Price Target: $25 → $23
Current: $17.99
Upside: +27.85%
Oct 23, 2025
Maintained: Sell
Price Target: $26 → $25
Current: $51.59
Upside: -51.54%
Oct 23, 2025
Maintained: Hold
Price Target: $121 → $120
Current: $89.59
Upside: +33.94%
Oct 20, 2025
Maintained: Hold
Price Target: n/a
Current: $101.24
Upside: -
Oct 17, 2025
Maintained: Sell
Price Target: $10
Current: $13.80
Upside: -27.54%
Oct 13, 2025
Maintained: Buy
Price Target: n/a
Current: $45.33
Upside: -
Oct 10, 2025
Maintained: Buy
Price Target: $473
Current: $303.64
Upside: +55.78%
Oct 9, 2025
Maintained: Buy
Price Target: $78 → $76
Current: $34.20
Upside: +122.22%
Oct 8, 2025
Maintained: Buy
Price Target: $517 → $530
Current: $441.74
Upside: +19.98%
Sep 24, 2025
Reiterated: Buy
Price Target: $53 → $52
Current: $34.63
Upside: +50.16%
Sep 12, 2025
Maintained: Buy
Price Target: $53 → $77
Current: $92.49
Upside: -16.75%
Sep 9, 2025
Maintained: Hold
Price Target: $34 → $35
Current: $43.38
Upside: -19.32%
Sep 9, 2025
Maintained: Buy
Price Target: $153
Current: $104.92
Upside: +45.83%
Sep 9, 2025
Maintained: Buy
Price Target: $450
Current: $547.69
Upside: -17.84%
Jun 16, 2025
Maintained: Buy
Price Target: n/a
Current: $30.91
Upside: -
May 6, 2025
Maintained: Buy
Price Target: $10 → $13
Current: $8.47
Upside: n/a
Apr 11, 2025
Maintained: Buy
Price Target: $50
Current: $28.76
Upside: n/a
Nov 20, 2023
Initiated Coverage: Sell
Price Target: n/a
Current: $8.44
Upside: n/a
Nov 20, 2023
Initiated Coverage: Hold
Price Target: n/a
Current: $3.13
Upside: n/a
Jun 7, 2022
Maintained: Hold
Price Target: $18 → $14
Current: $25.10
Upside: n/a
Apr 7, 2022
Maintained: Hold
Price Target: $7 → $5
Current: $1.90
Upside: n/a
Mar 14, 2022
Maintained: Buy
Price Target: $20 → $19
Current: $3.05
Upside: n/a
Aug 20, 2021
Downgraded: Sell
Price Target: n/a
Current: $0.7753
Upside: n/a
Aug 3, 2021
Downgraded: Hold
Price Target: $13 → $7
Current: $84.12
Upside: n/a
Apr 6, 2020
Maintained: Hold
Price Target: $94 → $66
Current: $148.08
Upside: n/a
Mar 19, 2018
Downgraded: Sell
Price Target: n/a
Current: $10.19
Upside: n/a
Feb 8, 2018
Downgraded: Hold
Price Target: $32 → $95
Current: $11.79
Upside: n/a